Log in or Sign up for Free to view tailored content for your specialty!
Leukemia News
Enrollment of trial assessing triplet for leukemia halted after ‘unexpected’ outcome
Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit.
Spouses of people with cancer more likely to attempt, die of suicide
Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.
Log in or Sign up for Free to view tailored content for your specialty!
Tisagenlecleucel ‘can be curative’ for some children with acute leukemia
Children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia increasingly receive tisagenlecleucel in earlier settings when they have lower disease burden, according to findings presented at ASCO Annual Meeting.
‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes
The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.
European Medicines Agency recommends MabThera biosimilar for multiple indications
The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the launch of proposed biosimilar rituximab candidate Ituxredi, Dr. Reddy’s Laboratories announced in a press release.
Acalabrutinib regimens improve PFS vs. standard care in untreated CLL
Fixed-duration acalabrutinib plus venetoclax, with or without obinutuzumab, improved survival compared with standard chemoimmunotherapy for certain adults with leukemia, according to a topline data announcement.
Blinatumomab regimen improves survival for certain patients with acute leukemia
Use of blinatumomab with consolidation chemotherapy significantly extended OS for adults with minimal residual disease-negative B-cell precursor acute lymphoblastic leukemia, according to randomized phase 3 study results.
Obe-cel improves EFS in advanced B-cell acute lymphoblastic leukemia
Obecabtagene autoleucel conferred durable benefit to certain patients with relapsed or refractory B-cell acute lymphoblastic leukemia, according to results of the phase 1B/phase 2 FLEIX study presented at ASCO Annual Meeting.
Studies find benzoyl peroxide for acne has no increased risk for blood benzene, malignancy
Patients with acne who used benzoyl peroxide products did not have a risk for malignancy or increased blood benzene levels, according to a pair of studies published in the Journal of the American Academy of Dermatology.
VIDEO: Asciminib results could yield ‘significant change’ in CML treatment
In this video, Eric Winer, MD, discusses the results of research into chronic myeloid leukemia presented at ASCO Annual Meeting.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read